M.D. Anderson Cancer Center: all 3,044 studies

Page 13 of 31. Open to participants first (578), then studies with results posted, then the rest; newest registration first within each.

• Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell SupportCompletedNCT00506857Phase 1/2Results posted
• Gleevec/Taxol for Patients With Uterine Papillary Serous CarcinomaTerminatedNCT00506779Phase 1/2Results posted
• Erwinase Study in Patients With Acute Lymphoblastic LeukemiaCompletedNCT00506597Not applicableResults posted
• Neoadjuvant Chemotherapy With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-VAC) Plus Avastin in Patients With Urothelial CancerCompletedNCT00506155Phase 2Results posted
• Allogeneic Transplantation in Patients With Cutaneous T-Cell LymphomaCompletedNCT00506129Phase 2Results posted
• Melatonin Postoperative Sleep Study in Breast Cancer PatientsTerminatedNCT00506064Phase 1Results posted
• Autologous and Allogenic Transplantation With Campath-1H for T-Cell LymphomaTerminatedNCT00505921Phase 2Results posted
• FM 140 vs FM100 Study in Patients With Multiple MyelomaCompletedNCT00505895Phase 2Results posted
• Letrozole in Patients With Ovarian TumorsTerminatedNCT00505661Phase 2Results posted
• Biochemotherapy With Temozolomide for Metastatic MelanomaTerminatedNCT00505635Phase 2Results posted
• Fatigue in Emergency Center PatientsTerminatedNCT00504985Results posted
• 6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma PatientsCompletedNCT00504660Phase 2Results posted
• Fibrin Melanoma Axillary Node Study in Patients With MelanomaCompletedNCT00504582Not applicableResults posted
• Rituximab and ABVD for Hodgkin's PatientsCompletedNCT00504504Phase 2Results posted
• Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal CancersCompletedNCT00503035Phase 2Results posted
• Busulfan and Fludarabine in Patients With AML and MDSCompletedNCT00502905Phase 2Results posted
• Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the UterusCompletedNCT00502203Phase 2Results posted
• Chemoimmunotherapy Study for Patients With Epithelial Ovarian CancerCompletedNCT00501644Phase 2Results posted
• Aspirin in Patients With Myocardial Infarction and ThrombocytopeniaTerminatedNCT00501345Phase 3Results posted
• Tissue Repair in Stem Cell Transplant RecipientsTerminatedNCT00501228Not applicableResults posted
• Treatment of Tumors of the Choroid Plexus EpitheliumTerminatedNCT00500890Phase 3Results posted
• Intermittent Use of Aerosolized Ribavirin for Treatment of RSVCompletedNCT00500578Phase 4Results posted
• Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL)TerminatedNCT00500240Phase 3Results posted
• Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate CancerCompletedNCT00500110Phase 2Results posted
• Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML PatientsTerminatedNCT00499889Phase 2Results posted
• Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast CancerStatus unknownNCT00499603Phase 2Results posted
• G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL PatientsCompletedNCT00499343Phase 2Results posted
• Evaluation of the Safety and Efficacy of Nipent, Cytoxan, and RituxanCompletedNCT00496873Phase 2Results posted
• Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the BreastCompletedNCT00496808Not applicableResults posted
• Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell CarcinomaCompletedNCT00496587Phase 2Results posted
• Concurrent Proton and Chemotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00495170Phase 2Results posted
• Proton Radiotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00495040Phase 2Results posted
• Effects of Rocking on Postoperative Ileus Duration StudyCompletedNCT00494806Early Phase 1Results posted
• CEP-701 for PH-negative MyelofibrosisCompletedNCT00494585Phase 2Results posted
• Zevalin (Ibritumomab Tiuxetan) for Early Stage Indolent LymphomasCompletedNCT00493467Phase 2Results posted
• Ibritumomab Tiuxetan for Treatment of Non-Follicular CD20+ Indolent LymphomasTerminatedNCT00493454Phase 2Results posted
• Interleukin 11, Thrombocytopenia, Imatinib in Chronic Myelogenous Leukemia (CML) PatientsCompletedNCT00493181Phase 2Results posted
• Evaluation of Single Session Stereotactic Body RadiotherapyCompletedNCT00492817Phase 1/2Results posted
• Bortezomib and Rituximab for Patients With Waldenstrom's MacroglobulinemiaActive, not recruitingNCT00492050Phase 2Results posted
• Pemetrexed Plus Gemcitabine in Renal Cell CancerTerminatedNCT00491075Phase 2Results posted
• Zoledronate With Atorvastatin in Renal Cell CarcinomaCompletedNCT00490698Phase 2Results posted
• A Pilot Trial of Image-Guided Adaptive Radiotherapy for Head and Neck CancerCompletedNCT00490282Not applicableResults posted
• Dexamethasone for Symptom Burden in Advanced Cancer PatientsActive, not recruitingNCT00489307Phase 2Results posted
• Combined Levothyroxine/Liothyronine Supplementation in Hypothyroid Patients With Brain TumorsTerminatedNCT00488644Not applicableResults posted
• Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell CancerCompletedNCT00485485Phase 2Results posted
• Oxaliplatin, Fludarabine, and Cytarabine in Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS)TerminatedNCT00480987Phase 1/2Results posted
• Iressa and Taxotere Study in Patients With Metastatic Urothelial CancerTerminatedNCT00479089Phase 2Results posted
• Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney FunctionCompletedNCT00478361Phase 2Results posted
• Bortezomib, Rituximab and Combination Chemotherapy in Treating Participants With Mantle Cell LymphomaCompletedNCT00477412Phase 1/2Results posted
• Thymoglobulin and Total Lymphoid Irradiation for Hematologic MalignanciesCompletedNCT00476229Not applicableResults posted
• Allogeneic Stem Cell Transplantation for Myelofibrosis and Myelodysplastic SyndromeCompletedNCT00475020Phase 2Results posted
• Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and LeukemiasCompletedNCT00472849Phase 1/2Results posted
• Rituximab in Addition to Autologous Transplantation With BEAM for Patients With Lymphoid MalignanciesCompletedNCT00472056Phase 2Results posted
• Velcade, Trisenox, Vitamin C and Melphalan for Myeloma PatientsCompletedNCT00469209Phase 1/2Results posted
• IV Busulfan With Allo-BMT: Study for Patients With Acute Myelogenous Leukemia and Myelodysplastic SyndromeCompletedNCT00469144Phase 3Results posted
• Busulfan, Fludarabine, Clofarabine With Allogeneic Stem Cell Transplantation for Acute Myeloid LeukemiaCompletedNCT00469014Phase 2Results posted
• Catheter Related - Gram Positive Bloodstream InfectionsCompletedNCT00467272Phase 2Results posted
• Sunitinib Malate in Patients With Non-Clear Cell Renal Cell CancerCompletedNCT00465179Phase 2Results posted
• Alemtuzumab and Pentostatin In T-cell NeoplasmsTerminatedNCT00453193Phase 2Results posted
• A Study of Actonel for the Prevention of Bone LossCompletedNCT00452439Phase 3Results posted
• Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLLCompletedNCT00452374Phase 1/2Results posted
• Pegasys® in Patients With Myeloproliferative DiseasesCompletedNCT00452023Phase 2Results posted
• Everolimus (RAD001) as Therapy for Patients With Systemic MastocytosisCompletedNCT00449748Phase 2Results posted
• FCR and Bevacizumab in the Treatment of Relapsed Chronic Lymphocytic Leukemia (CLL)CompletedNCT00448019Phase 2Results posted
• Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell TransplantCompletedNCT00439556Phase 2Results posted
• Proton Beam Radiation Therapy for Intraocular and Periocular RetinoblastomaTerminatedNCT00432445Phase 2Results posted
• Mini-Allogeneic Peripheral Blood Progenitor Cell Transplantation For Recurrent or Metastatic Breast CancerCompletedNCT00429572Phase 2Results posted
• Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only MetastasesCompletedNCT00429507Phase 2Results posted
• GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation PatientsCompletedNCT00429494Phase 2Results posted
• Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast CancerTerminatedNCT00429403Phase 3Results posted
• Purged Circulating Tumor Cells (CTCs) From Metastatic Breast CancerCompletedNCT00429182Phase 2Results posted
• Herceptin and GM-CSF for Metastatic Breast CancerCompletedNCT00429104Phase 2Results posted
• Conditioning Regimen in Nonmyeloablative Allogeneic Hematopoietic Stem Cell TransplantationTerminatedNCT00429026Phase 2Results posted
• Rituximab to the Preparative Regimen of Etoposide and Total Body Irradiation in Acute Lymphoblastic LeukemiaCompletedNCT00427791Phase 2Results posted
• Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple MyelomaCompletedNCT00427765Phase 2Results posted
• Cellular Therapy With Cord Blood CellsCompletedNCT00427557Phase 2Results posted
• Purine Analog-Based Conditioning in Patients With Severe Aplastic AnemiaCompletedNCT00427336Not applicableResults posted
• Voraxaze for Delayed Methotrexate ClearanceTerminatedNCT00424645Phase 1/2Results posted
• Methylphenidate and a Nursing Telephone Intervention for FatigueCompletedNCT00424099Phase 2/3Results posted
• Parenteral Hydration in Advanced Cancer PatientsCompletedNCT00423722Not applicableResults posted
• Interactive Voice Response (IVR) Symptom Assessment in Non-Small Cell Lung Cancer (NSCLC) PatientsCompletedNCT00423436Not applicableResults posted
• Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML)CompletedNCT00422591Phase 2Results posted
• 2 Arm Study of Clofarabine IV in MDS PatientsCompletedNCT00422032Phase 2Results posted
• Liposomal Amphotericin B (Ambisome) Versus Oral Voriconazole for the Prevention of Invasive Fungal InfectionsCompletedNCT00418951Phase 2Results posted
• Effects of Methylphenidate Versus Sustained Release Methylphenidate on Cognitive FunctioningTerminatedNCT00418691Phase 3Results posted
• TALL-104 and Gleevec in Chronic Myelogenous Leukemia PatientsTerminatedNCT00415909Phase 2Results posted
• Proteinase 3 PR1 Peptide Mixed With Montanide ISA-51 VG Adjuvant and Administered With GM-CSF and PEG-INTRON(R)TerminatedNCT00415857Phase 2Results posted
• Decitabine (DAC) w/ or w/o Valproic Acid (VPA) in Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)CompletedNCT00414310Phase 2Results posted
• Letrozole Versus Observation in Patients With Newly Diagnosed Uterine LeiomyosarcomaTerminatedNCT00414076Phase 2Results posted
• 5-Azacytidine (Azacytidine; Vidaza) in Chronic Lymphocytic LeukemiaTerminatedNCT00413478Phase 2Results posted
• All-trans Retinoic Acid, and Arsenic +/- IdarubicinCompletedNCT00413166Phase 2Results posted
• Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With GliomasCompletedNCT00412542Phase 2Results posted
• Palonosetron for Prevention of Biochemotherapy Induced Nausea and VomitingCompletedNCT00412425Phase 1/2Results posted
• Clofarabine and Cyclophosphamide Combination in Acute Lymphoblastic Leukemia PatientsCompletedNCT00412243Phase 1/2Results posted
• BATTLE Program: Sorafenib in Patients With NSCLCCompletedNCT00411671Phase 2Results posted
• BATTLE Program: Tarceva and Targretin in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00411632Phase 2Results posted
• Rituximab and GM-CSF in Treating Patients With Newly Diagnosed Follicular B-Cell LymphomaCompletedNCT00411086Phase 2Results posted
• Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)CompletedNCT00410488Not applicableResults posted
• BATTLE Program: ZD6474 in Previously Treated Subjects With NSCLCCompletedNCT00410189Phase 2Results posted
• BATTLE Program: Erlotinib in Previously Treated Subjects With Advanced NSCLCCompletedNCT00410059Phase 2Results posted

← M.D. Anderson Cancer Center overview and focus areas